📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-19 10:18
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
1,000+ announcements match the current filters (relevance ≥ 5).
L&T Secures LNTP for Ultra-Mega (>₹15,000 Cr) New Tashkent International Airport Project
Larsen & Toubro's Public Spaces, Airports & Health vertical secured a Limited Notice to Proceed (LNTP) for the New Tashkent International Airport in Uzbekistan. The order is classified as 'Ultra-Mega', indicating a contract value exceeding ₹15,000 Cr, which accounts for over 5.17% of L&T's TTM revenue (₹290,137 Cr). Under the LNTP, L&T has commenced pre-construction activities including engineering, design, and procurement preparation, while construction of the terminal catering to 17 million annual passengers will start after the full Notice to Proceed (NTP) is issued.
Confidence: HIGH
What changedL&T received a Limited Notice to Proceed from a PPP consortium to commence pre-construction activities for the New Tashkent International Airport.
Why it mattersAdds a minimum of ₹15,000 Cr to L&T's international order pipeline, marking a major infrastructure footprint expansion into Central Asia.
Contract classification threshold: > 15,000 CrAnnual passenger capacity: approximately 17 millionMinimum order value vs TTM revenue: ~5.17%
📅 Short termPositive sentiment for the stock driven by a major international airport EPC win, though revenue recognition will be modest initially under the LNTP stage.
📈 Long termStrengthens L&T's credentials as a global airport EPC player and diversifies its international revenue base beyond traditional Middle Eastern markets.
⚠ Risk flags
- Execution dependent on the issuance of the full Notice to Proceed upon fulfilment of contractual conditions precedent
- Cross-border execution and currency/geopolitical risks in Central Asia
Key Highlights
Order classified as Ultra-Mega, indicating a value exceeding ₹15,000 Cr
Scope includes passenger terminal and landside infrastructure designed for approximately 17 million passengers annually
Represents at least 5.17% of TTM revenue of ₹290,137 Cr
Current scope is under a Limited Notice to Proceed (LNTP) covering pre-construction design and engineering ahead of full NTP
👀 What to Watch
Track the receipt of the full Notice to Proceed (NTP) post-fulfilment of contractual conditions precedent, which will initiate on-site construction.
Alembic Pharma Gets USFDA Final Approval for Otic Suspension Targeting $110M US Market
Alembic Pharmaceuticals has received final approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Ciprofloxacin and Dexamethasone Otic Suspension USP, 0.3% / 0.1%. The drug is therapeutically equivalent to Sandoz's Ciprodex and targets an estimated US market size of $110 million (~₹920 crore) for the twelve months ending June 2026. This approval takes Alembic's cumulative tally to 246 ANDA approvals (226 final and 20 tentative approvals). The launch supports the company's stated strategy to launch 15-20 products in the US in FY26 to improve capacity utilization.
Confidence: HIGH
What changedAlembic Pharma obtained final USFDA regulatory clearance to commercialize a generic alternative to Ciprodex Otic Suspension in the US.
Why it mattersAdds an addressable market of US$110 million to Alembic's US generics pipeline, aiding its target of 15-20 US launches in FY26 and helping absorb overheads from new manufacturing facilities.
US market size (12M ending Jun 2026): US$110 millionMarket size vs TTM Revenue (~Rs 7,784 Cr): ~11.8%Cumulative USFDA ANDA approvals: 246Cumulative final approvals: 226
📅 Short termPositive sentiment from regulatory clearance, though revenue contribution will depend on the timing of distribution and market competition.
📈 Long termSupports operating leverage as increased volumes from US generic launches help reduce the ~Rs 150 Cr unabsorbed overhead drag seen across its newly approved facilities.
⚠ Risk flags
- Intense generic pricing erosion in the US market
- Market share fragmentation among multiple generic players
Key Highlights
Final USFDA approval for Ciprofloxacin and Dexamethasone Otic Suspension USP, 0.3% / 0.1%
Estimated addressable US market size is US$110 million for the 12 months ending June 2026
Cumulative USFDA approvals reach 246 ANDAs, comprising 226 final and 20 tentative approvals
Therapeutically equivalent to Sandoz Inc.'s reference listed drug Ciprodex Otic Suspension
👀 What to Watch
Track the commercial launch date and market share capture in the US against generic competition, as well as management commentary in upcoming quarterly results regarding facility capacity utilization.
Kellton Tech Approves ₹160 Cr Rights Issue; Appoints New Compliance Officer
Kellton Tech Solutions Limited has approved a fundraise of up to ₹160 crore via a Rights Issue of equity shares of face value Re 1 each. This proposed issue is substantial, representing approximately 23.8% of the company's current market capitalization of ₹671 crore and 52.5% of its net worth (₹305 crore). The board also approved the Draft Letter of Offer, while issue price, entitlement ratio, and record date will be determined subsequently. Additionally, the company appointed Ms. Muskan Manucha as Company Secretary and Compliance Officer effective October 18, 2026.
Confidence: HIGH
What changedBoard approved a capital raise of up to ₹160 crore via Rights Issue and appointed a new Company Secretary & Compliance Officer.
Why it mattersA ₹160 crore equity expansion is material relative to the company's ₹305 crore net worth, providing balance sheet support for growth or acquisitions while risking equity dilution.
Rights Issue Size: Rs. 160 CroresFace Value per share: Re. 1/-Issue size vs Market Cap: ~23.8%Issue size vs Net Worth: ~52.5%
📅 Short termShare price may see volatility depending on the discount offered in the upcoming rights issue pricing and dilution terms.
📈 Long termInfusion of equity capital will improve liquidity and support Kellton's stated inorganic acquisition strategy, though earnings per share will face dilution.
⚠ Risk flags
- Equity dilution risk depending on the rights issue ratio and pricing discount
- Terms such as issue price and entitlement ratio remain undetermined
Key Highlights
Approved Rights Issue of equity shares for an aggregate amount up to ₹160 crore
Fundraise size represents ~23.8% of the company's current market cap of ₹671 crore
Draft Letter of Offer approved; pricing and rights ratio to be decided subsequently
Appointed Ms. Muskan Manucha as Company Secretary & Compliance Officer effective October 18, 2026
👀 What to Watch
Track subsequent announcements regarding the Rights Issue pricing, entitlement ratio, and record date to evaluate the dilution impact and net proceeds utilization.
Kellton Tech Approves ₹160 Cr Rights Issue; Appoints New Compliance Officer
Kellton Tech Solutions Limited has approved a fundraise of up to ₹160 crore via a Rights Issue of equity shares of face value Re 1 each. This proposed issue is substantial, representing approximately 23.8% of the company's current market capitalization of ₹671 crore and 52.5% of its net worth (₹305 crore). The board also approved the Draft Letter of Offer, while issue price, entitlement ratio, and record date will be determined subsequently. Additionally, the company appointed Ms. Muskan Manucha as Company Secretary and Compliance Officer effective October 18, 2026.
Confidence: HIGH
What changedBoard approved a capital raise of up to ₹160 crore via Rights Issue and appointed a new Company Secretary & Compliance Officer.
Why it mattersA ₹160 crore equity expansion is material relative to the company's ₹305 crore net worth, providing balance sheet support for growth or acquisitions while risking equity dilution.
Rights Issue Size: Rs. 160 CroresFace Value per share: Re. 1/-Issue size vs Market Cap: ~23.8%Issue size vs Net Worth: ~52.5%
📅 Short termShare price may see volatility depending on the discount offered in the upcoming rights issue pricing and dilution terms.
📈 Long termInfusion of equity capital will improve liquidity and support Kellton's stated inorganic acquisition strategy, though earnings per share will face dilution.
⚠ Risk flags
- Equity dilution risk depending on the rights issue ratio and pricing discount
- Terms such as issue price and entitlement ratio remain undetermined
Key Highlights
Approved Rights Issue of equity shares for an aggregate amount up to ₹160 crore
Fundraise size represents ~23.8% of the company's current market cap of ₹671 crore
Draft Letter of Offer approved; pricing and rights ratio to be decided subsequently
Appointed Ms. Muskan Manucha as Company Secretary & Compliance Officer effective October 18, 2026
👀 What to Watch
Track subsequent announcements regarding the Rights Issue pricing, entitlement ratio, and record date to evaluate the dilution impact and net proceeds utilization.
Agarwal Toughened Glass wins ₹4.24 Cr supply order for Jaipur medical college
Agarwal Toughened Glass has secured a purchase order valued at approximately ₹4.24 crore from a domestic entity for a medical college project in Jaipur, Rajasthan. The scope includes supplying approximately 12,500 SQM of DGU (Double Glazed Unit) and value-added toughened glass. The project execution is slated for completion by March 2027. Against a TTM revenue of ₹150 crore, this single order represents roughly 2.8% of annual sales.
Confidence: HIGH
What changedSecured a new commercial contract worth ₹4.24 crore for architectural glass supply in Rajasthan.
Why it mattersAdds to the company's order pipeline in value-added glass (DGU), supporting higher-margin product volume despite being modest relative to TTM revenue.
Order value: ₹4.24 CroreGlass volume: 12500 SQMExecution deadline: March 2027Order vs TTM revenue: ~2.8%
📅 Short termPositive sentiment for order inflow in specialized glass, though financial contribution will be spread over several months.
📈 Long termDemonstrates traction in securing institutional architectural projects for high-specification DGU products.
⚠ Risk flags
- Execution timeline delays extending towards March 2027
- Domestic client concentration/unnamed counterparty
Key Highlights
Received purchase order valued at approximately ₹4.24 crore
Scope covers supply of ~12,500 SQM of DGU/SGU value-added glass
Target completion timeline set for March 2027
Contract is in the normal course of business with no related-party involvement
👀 What to Watch
Track execution milestones and revenue recognition across upcoming quarterly earnings leading up to the March 2027 target.
RailTel Secures Rs 18.99 Cr Cybersecurity & IT Order from Health Insurance TPA
RailTel Corporation of India Ltd. has received a purchase order valued at Rs 18.99 crore (inclusive of tax) from Health Insurance TPA of India Ltd. The domestic non-telecom contract is for IT infrastructure and cybersecurity solutions over a 3-year execution period ending on October 16, 2029. While financially minor relative to RailTel's TTM revenue of Rs 3,326 crore (representing ~0.57%), it aligns with the company's strategy to expand into non-railway ICT and cybersecurity domains.
Confidence: HIGH
What changedRailTel won a 3-year domestic IT infrastructure and cybersecurity order worth Rs 18.99 crore from Health Insurance TPA of India Ltd.
Why it mattersThe deal represents incremental diversification into non-railway healthcare ICT, though its financial scale is very small compared to RailTel's annual revenue base.
Order value: Rs. 18,99,03,173/- (Including Tax)Order vs TTM revenue: ~0.57%Execution tenure: 3 years (ending 16-OCT-29)
📅 Short termLimited share price impact expected given the small contract value relative to the company's Rs 8,197 crore market cap.
📈 Long termLimited structurally due to small size, but reinforces RailTel's expansion into enterprise cybersecurity and non-railway digital services.
⚠ Risk flags
- Project execution and service-level agreement risks over a 3-year term
- Historically lower margins in project-based non-telecom ICT contracts
Key Highlights
Order size is Rs 18,99,03,173 (inclusive of tax)
Contract duration is 3 years, scheduled for completion by 16-OCT-2029
Awarded by Health Insurance TPA of India Ltd. for IT infrastructure and cybersecurity solutions
Categorized as a domestic, non-telecom order
👀 What to Watch
Track execution progress and margin delivery in the non-telecom/ICT segment in upcoming quarterly earnings.
Oberoi Realty Q2FY27 PAT at ₹759.01 Cr; H1 Bookings Surge to ₹10,199.57 Cr
Oberoi Realty reported a sequential improvement for Q2FY27 with consolidated revenue of ₹1,736.37 crore (up 27.5% QoQ from ₹1,361.69 crore) and PAT of ₹759.01 crore (up 39.3% QoQ from ₹544.71 crore). Booking value saw an exceptional jump, clocking ₹9,149.69 crore in Q2 alone, pushing H1FY27 booking value to ₹10,199.57 crore versus ₹2,937.73 crore in H1FY26. H1FY27 consolidated revenue reached ₹3,098.06 crore compared to ₹2,918.82 crore in H1FY26, while EBITDA for H1 stood at ₹1,879.53 crore.
Confidence: HIGH
What changedOberoi Realty published its financial results for Q2FY27 and H1FY27, highlighted by a record quarterly pre-sales booking value of ₹9,149.69 crore.
Why it mattersPre-sales booking values (₹10,199.57 crore in H1FY27) significantly outpace the company's full-year FY26 revenue of ₹6,009.23 crore, securing high future revenue visibility as projects progress towards completion.
Q2FY27 Booking Value: Rs. 9,149.69 croresH1FY27 Booking Value: Rs. 10,199.57 croresH1 Booking vs TTM Revenue: ~161.3%Q2FY27 Revenue: Rs. 1,736.37 croresQ2FY27 PAT: Rs. 759.01 croresH1FY27 PAT: Rs. 1,303.72 crores
📅 Short termPositive sentiment driven by the massive surge in booking value and healthy sequential recovery in both revenue and profit.
📈 Long termExpansion beyond MMR into NCR with 'Three Sixty North', combined with strong delivery pipelines and expanding annuity assets, strengthens structural earnings growth.
⚠ Risk flags
- Execution and handover timelines controlling revenue recognition under percentage-completion accounting
- Geographic concentration risks outside MMR as NCR operations scale
Key Highlights
Q2FY27 booking value surged to ₹9,149.69 crore, driving H1FY27 booking value to ₹10,199.57 crore (up 247% YoY from ₹2,937.73 crore)
Q2FY27 consolidated revenue stood at ₹1,736.37 crore versus ₹1,361.69 crore in Q1FY27
Q2FY27 PAT rose to ₹759.01 crore from ₹544.71 crore in Q1FY27
H1FY27 consolidated PAT reached ₹1,303.72 crore compared to ₹1,180.46 crore in H1FY26
EBITDA reached ₹1,084.59 crore in Q2FY27 and ₹1,879.53 crore for H1FY27
👀 What to Watch
Track execution and revenue recognition timelines for the massive H1 bookings (over ₹10,000 crore), alongside sales momentum in the newly launched NCR project (Three Sixty North) entering the festive season.
Rollatainers Gets In-Principle Approval for 35.87 Cr Warrants at Min ₹2.23 Each
Rollatainers Limited has secured in-principle approval from BSE and NSE on October 16, 2026, to issue 35,87,44,394 warrants convertible into equity shares. The warrants will be issued on a preferential basis to promoters and non-promoters at a floor price of not less than ₹2.23 each. If fully subscribed and converted, this fundraise would aggregate at least ~₹80.0 Cr, representing roughly 68% of the company's current market cap of ₹117 Cr. This follows the sale of its core operating subsidiary RT Packaging, leaving the parent with negligible operational revenue.
Confidence: HIGH
What changedBSE and NSE granted in-principle listing approval under Regulation 28(1) for 35.87 crore convertible warrants issued on a preferential basis.
Why it mattersA fundraise of at least ₹80 Cr would substantially strengthen Rollatainers' net worth (₹9 Cr) and provide capital to restart operations following the divestment of its main operating subsidiary.
Warrants to be issued: 35,87,44,394Issue floor price per warrant: Rs. 2.23Face value per share: Rs. 1Minimum capital to be raised: ~₹80.0 CrMinimum raise vs Market Cap: ~68%
📅 Short termThe stock may react positively to the formal regulatory clearance for fresh equity capital, though pricing at ₹2.23 represents a sharp discount to the prevailing market price of ₹4.70.
📈 Long termIf successfully converted, the cash infusion could revive operations or fund new business activities, but will lead to massive equity dilution.
⚠ Risk flags
- Severe equity dilution from 35.87 crore new shares
- Substantial discount of issue price (₹2.23) vs market price (₹4.70)
- Core business operations currently generate zero standalone operational revenue
Key Highlights
In-principle approval received from BSE and NSE on October 16, 2026
Approval covers issuance of 35,87,44,394 convertible warrants into an equivalent number of equity shares
Floor issue price fixed at not less than ₹2.23 per warrant/share (face value ₹1 each)
Minimum gross fundraise potential of ₹80.00 Cr, compared to current market cap of ₹117 Cr
👀 What to Watch
Track the subsequent board allotment, shareholder approvals, and actual subscription details along with promoter participation to monitor balance sheet recapitalisation.
LTM Declares ₹25/Share Interim Dividend; Q2 Revenue Rises to ₹11,807.6 Cr
LTM Limited announced an interim dividend of ₹25 per equity share of face value ₹1 for FY27, setting the record date as October 23, 2026. Alongside the dividend, the company reported consolidated Q2 revenue from operations of ₹11,807.6 crore (₹118,076 million), up 13.6% YoY from ₹10,394.3 crore (₹103,943 million) in Q2 FY26. Consolidated profit before tax stood at ₹1,859.7 crore (₹18,597 million) for the quarter. The dividend payout is scheduled to be completed within 30 days of declaration.
Confidence: HIGH
What changedThe Board declared an interim dividend of ₹25 per share and approved unaudited financial results for Q2 ended September 30, 2026.
Why it mattersProvides immediate cash return to shareholders backed by continued top-line growth (Q2 revenue up ~13.6% YoY).
Interim dividend per share: INR 25/-Record date: October 23, 2026Q2 Consolidated Revenue: 118,076 millionQ2 Consolidated PBT: 18,597 million
📅 Short termThe stock will trade ex-dividend ahead of October 23, 2026; price action will also digest the Q2 earnings release and margin performance.
📈 Long termDemonstrates consistent capital return policy and business stability as revenue expanded to ₹11,807.6 crore for the quarter.
Key Highlights
Declared interim dividend of INR 25/- per equity share of Re. 1 each
Record date fixed as Friday, October 23, 2026
Q2 revenue from operations reported at INR 118,076 million vs INR 103,943 million in Q2 prior year
Profit before tax stood at INR 18,597 million for the quarter ended September 30, 2026
Appointed Mr. Anupam Kumar as Additional Non-Executive Non-Independent Director effective October 16, 2026
👀 What to Watch
Eligible shareholders must hold shares before the record date of October 23, 2026, to receive the ₹25 dividend. Investors should also monitor commentary from the Q2 earnings call regarding margin trajectory and demand outlook.
Oberoi Realty Declares 2nd Interim Dividend of ₹2 Per Share (20%) for FY27
Oberoi Realty has declared a second interim dividend of ₹2 per equity share of face value ₹10 each (20%) for FY26-27. The Board of Directors finalized the record date as October 23, 2026, to determine eligible shareholders. The dividend payout is scheduled to commence on October 30, 2026. Relative to the current share price of ₹1,703, this interim payout represents an absolute dividend yield of approximately 0.12%.
Confidence: HIGH
What changedThe Board of Directors approved a 2nd interim dividend of ₹2 per share for FY26-27 with a set timeline for record date and disbursement.
Why it mattersDemonstrates continued periodic cash return to shareholders, though the quantum is small relative to the share price and annual net profit (FY26 PAT of ₹2,507 Cr).
Interim Dividend per share: Rs. 2/-Dividend % of Face Value: 20%Face Value: Rs. 10/-Record Date: October 23, 2026Payment Date: October 30, 2026
📅 Short termStock will trade ex-dividend ahead of the October 23, 2026 record date; market reaction is expected to be muted given the minor yield.
📈 Long termLimited; routine capital return that does not alter the structural growth trajectory or project execution outlook in the MMR region.
Key Highlights
2nd Interim Dividend declared at ₹2 per equity share
Payout represents 20% of the face value (₹10 each)
Record date fixed for October 23, 2026
Dividend disbursement scheduled to commence on October 30, 2026
👀 What to Watch
Investors seeking dividend eligibility must hold shares before the ex-dividend date prior to October 23, 2026. Watch for Q2 FY27 earnings disclosures to assess overall cash generation and booking trends.
LTM Declares ₹25/Share Interim Dividend; Q2 Revenue Rises to ₹11,807.6 Cr
LTM Limited announced an interim dividend of ₹25 per equity share of face value ₹1 for FY27, setting the record date as October 23, 2026. Alongside the dividend, the company reported consolidated Q2 revenue from operations of ₹11,807.6 crore (₹118,076 million), up 13.6% YoY from ₹10,394.3 crore (₹103,943 million) in Q2 FY26. Consolidated profit before tax stood at ₹1,859.7 crore (₹18,597 million) for the quarter. The dividend payout is scheduled to be completed within 30 days of declaration.
Confidence: HIGH
What changedThe Board declared an interim dividend of ₹25 per share and approved unaudited financial results for Q2 ended September 30, 2026.
Why it mattersProvides immediate cash return to shareholders backed by continued top-line growth (Q2 revenue up ~13.6% YoY).
Interim dividend per share: INR 25/-Record date: October 23, 2026Q2 Consolidated Revenue: 118,076 millionQ2 Consolidated PBT: 18,597 million
📅 Short termThe stock will trade ex-dividend ahead of October 23, 2026; price action will also digest the Q2 earnings release and margin performance.
📈 Long termDemonstrates consistent capital return policy and business stability as revenue expanded to ₹11,807.6 crore for the quarter.
Key Highlights
Declared interim dividend of INR 25/- per equity share of Re. 1 each
Record date fixed as Friday, October 23, 2026
Q2 revenue from operations reported at INR 118,076 million vs INR 103,943 million in Q2 prior year
Profit before tax stood at INR 18,597 million for the quarter ended September 30, 2026
Appointed Mr. Anupam Kumar as Additional Non-Executive Non-Independent Director effective October 16, 2026
👀 What to Watch
Eligible shareholders must hold shares before the record date of October 23, 2026, to receive the ₹25 dividend. Investors should also monitor commentary from the Q2 earnings call regarding margin trajectory and demand outlook.
LTM Declares ₹25/Share Interim Dividend; Q2 Revenue Rises to ₹11,807.6 Cr
LTM Limited announced an interim dividend of ₹25 per equity share of face value ₹1 for FY27, setting the record date as October 23, 2026. Alongside the dividend, the company reported consolidated Q2 revenue from operations of ₹11,807.6 crore (₹118,076 million), up 13.6% YoY from ₹10,394.3 crore (₹103,943 million) in Q2 FY26. Consolidated profit before tax stood at ₹1,859.7 crore (₹18,597 million) for the quarter. The dividend payout is scheduled to be completed within 30 days of declaration.
Confidence: HIGH
What changedThe Board declared an interim dividend of ₹25 per share and approved unaudited financial results for Q2 ended September 30, 2026.
Why it mattersProvides immediate cash return to shareholders backed by continued top-line growth (Q2 revenue up ~13.6% YoY).
Interim dividend per share: INR 25/-Record date: October 23, 2026Q2 Consolidated Revenue: 118,076 millionQ2 Consolidated PBT: 18,597 million
📅 Short termThe stock will trade ex-dividend ahead of October 23, 2026; price action will also digest the Q2 earnings release and margin performance.
📈 Long termDemonstrates consistent capital return policy and business stability as revenue expanded to ₹11,807.6 crore for the quarter.
Key Highlights
Declared interim dividend of INR 25/- per equity share of Re. 1 each
Record date fixed as Friday, October 23, 2026
Q2 revenue from operations reported at INR 118,076 million vs INR 103,943 million in Q2 prior year
Profit before tax stood at INR 18,597 million for the quarter ended September 30, 2026
Appointed Mr. Anupam Kumar as Additional Non-Executive Non-Independent Director effective October 16, 2026
👀 What to Watch
Eligible shareholders must hold shares before the record date of October 23, 2026, to receive the ₹25 dividend. Investors should also monitor commentary from the Q2 earnings call regarding margin trajectory and demand outlook.
Paushak Q2 FY27 PAT Rises 57% YoY to ₹13.51 Cr; Revenue Up 52% YoY to ₹89.32 Cr
Paushak reported strong Q2 FY27 performance with revenue from operations growing 52.0% YoY to ₹89.32 Cr compared to ₹58.78 Cr in Q2 FY26. Profit after tax rose 56.9% YoY to ₹13.51 Cr from ₹8.61 Cr, though it moderated 10.5% sequentially from ₹15.10 Cr in Q1 FY27. For H1 FY27, net profit expanded 38.6% YoY to ₹28.62 Cr on revenue of ₹172.87 Cr. The company's basic EPS for the quarter stood at ₹5.48, and net cash generated from operations strengthened to ₹40.72 Cr in H1 FY27.
Confidence: HIGH
What changedPaushak reported its Q2 and H1 FY27 results, showing over 50% top-line growth driven by higher volume throughput.
Why it mattersDemonstrates commercialization and volume gains from recent downstream capex expansions, re-accelerating profit growth after a muted FY26.
Revenue from Operations (Q2): ₹8,932 lacsProfit After Tax (Q2): ₹1,351 lacsH1 FY27 Revenue: ₹17,287 lacsOperating Cash Flow (H1): ₹4,071.98 lacsH1 Revenue vs TTM Revenue: ~70%
📅 Short termEarnings show strong YoY recovery and top-line momentum, which may be received positively despite slight QoQ net profit contraction.
📈 Long termOperating leverage from the phosgene downstream expansions and 'China Plus One' positioning remains the primary multi-year growth driver.
⚠ Risk flags
- Sequentially lower margins and PAT (QoQ PAT down 10.5%)
- Significant rise in trade receivables to ₹77.18 Cr from ₹54.86 Cr as of March 2026
Key Highlights
Revenue from operations grew 51.96% YoY to ₹8,932 lacs (₹89.32 Cr) in Q2 FY27
Profit after tax increased 56.91% YoY to ₹1,351 lacs (₹13.51 Cr)
H1 FY27 revenue reached ₹17,287 lacs (₹172.87 Cr), up 50.77% YoY
Net cash inflow from operating activities reached ₹4,071.98 lacs in H1 FY27 vs ₹2,468.45 lacs in H1 FY26
Quarterly basic EPS stood at ₹5.48 compared to ₹3.49 in Q2 FY26
👀 What to Watch
Track capacity ramp-up from recent capital expenditure (CWIP reduced to ₹16.16 Cr) and monitor if operating margins hold up against chemical raw material price fluctuations.
LTM Declares ₹25/Share Interim Dividend; Q2 Revenue Rises to ₹11,807.6 Cr
LTM Limited announced an interim dividend of ₹25 per equity share of face value ₹1 for FY27, setting the record date as October 23, 2026. Alongside the dividend, the company reported consolidated Q2 revenue from operations of ₹11,807.6 crore (₹118,076 million), up 13.6% YoY from ₹10,394.3 crore (₹103,943 million) in Q2 FY26. Consolidated profit before tax stood at ₹1,859.7 crore (₹18,597 million) for the quarter. The dividend payout is scheduled to be completed within 30 days of declaration.
Confidence: HIGH
What changedThe Board declared an interim dividend of ₹25 per share and approved unaudited financial results for Q2 ended September 30, 2026.
Why it mattersProvides immediate cash return to shareholders backed by continued top-line growth (Q2 revenue up ~13.6% YoY).
Interim dividend per share: INR 25/-Record date: October 23, 2026Q2 Consolidated Revenue: 118,076 millionQ2 Consolidated PBT: 18,597 million
📅 Short termThe stock will trade ex-dividend ahead of October 23, 2026; price action will also digest the Q2 earnings release and margin performance.
📈 Long termDemonstrates consistent capital return policy and business stability as revenue expanded to ₹11,807.6 crore for the quarter.
Key Highlights
Declared interim dividend of INR 25/- per equity share of Re. 1 each
Record date fixed as Friday, October 23, 2026
Q2 revenue from operations reported at INR 118,076 million vs INR 103,943 million in Q2 prior year
Profit before tax stood at INR 18,597 million for the quarter ended September 30, 2026
Appointed Mr. Anupam Kumar as Additional Non-Executive Non-Independent Director effective October 16, 2026
👀 What to Watch
Eligible shareholders must hold shares before the record date of October 23, 2026, to receive the ₹25 dividend. Investors should also monitor commentary from the Q2 earnings call regarding margin trajectory and demand outlook.
Paushak Q2 FY27 PAT Rises 57% YoY to ₹13.51 Cr; Revenue Up 52% YoY to ₹89.32 Cr
Paushak reported strong Q2 FY27 performance with revenue from operations growing 52.0% YoY to ₹89.32 Cr compared to ₹58.78 Cr in Q2 FY26. Profit after tax rose 56.9% YoY to ₹13.51 Cr from ₹8.61 Cr, though it moderated 10.5% sequentially from ₹15.10 Cr in Q1 FY27. For H1 FY27, net profit expanded 38.6% YoY to ₹28.62 Cr on revenue of ₹172.87 Cr. The company's basic EPS for the quarter stood at ₹5.48, and net cash generated from operations strengthened to ₹40.72 Cr in H1 FY27.
Confidence: HIGH
What changedPaushak reported its Q2 and H1 FY27 results, showing over 50% top-line growth driven by higher volume throughput.
Why it mattersDemonstrates commercialization and volume gains from recent downstream capex expansions, re-accelerating profit growth after a muted FY26.
Revenue from Operations (Q2): ₹8,932 lacsProfit After Tax (Q2): ₹1,351 lacsH1 FY27 Revenue: ₹17,287 lacsOperating Cash Flow (H1): ₹4,071.98 lacsH1 Revenue vs TTM Revenue: ~70%
📅 Short termEarnings show strong YoY recovery and top-line momentum, which may be received positively despite slight QoQ net profit contraction.
📈 Long termOperating leverage from the phosgene downstream expansions and 'China Plus One' positioning remains the primary multi-year growth driver.
⚠ Risk flags
- Sequentially lower margins and PAT (QoQ PAT down 10.5%)
- Significant rise in trade receivables to ₹77.18 Cr from ₹54.86 Cr as of March 2026
Key Highlights
Revenue from operations grew 51.96% YoY to ₹8,932 lacs (₹89.32 Cr) in Q2 FY27
Profit after tax increased 56.91% YoY to ₹1,351 lacs (₹13.51 Cr)
H1 FY27 revenue reached ₹17,287 lacs (₹172.87 Cr), up 50.77% YoY
Net cash inflow from operating activities reached ₹4,071.98 lacs in H1 FY27 vs ₹2,468.45 lacs in H1 FY26
Quarterly basic EPS stood at ₹5.48 compared to ₹3.49 in Q2 FY26
👀 What to Watch
Track capacity ramp-up from recent capital expenditure (CWIP reduced to ₹16.16 Cr) and monitor if operating margins hold up against chemical raw material price fluctuations.
Oberoi Realty Declares 2nd Interim Dividend of ₹2 Per Share (20%) for FY27
Oberoi Realty has declared a second interim dividend of ₹2 per equity share of face value ₹10 each (20%) for FY26-27. The Board of Directors finalized the record date as October 23, 2026, to determine eligible shareholders. The dividend payout is scheduled to commence on October 30, 2026. Relative to the current share price of ₹1,703, this interim payout represents an absolute dividend yield of approximately 0.12%.
Confidence: HIGH
What changedThe Board of Directors approved a 2nd interim dividend of ₹2 per share for FY26-27 with a set timeline for record date and disbursement.
Why it mattersDemonstrates continued periodic cash return to shareholders, though the quantum is small relative to the share price and annual net profit (FY26 PAT of ₹2,507 Cr).
Interim Dividend per share: Rs. 2/-Dividend % of Face Value: 20%Face Value: Rs. 10/-Record Date: October 23, 2026Payment Date: October 30, 2026
📅 Short termStock will trade ex-dividend ahead of the October 23, 2026 record date; market reaction is expected to be muted given the minor yield.
📈 Long termLimited; routine capital return that does not alter the structural growth trajectory or project execution outlook in the MMR region.
Key Highlights
2nd Interim Dividend declared at ₹2 per equity share
Payout represents 20% of the face value (₹10 each)
Record date fixed for October 23, 2026
Dividend disbursement scheduled to commence on October 30, 2026
👀 What to Watch
Investors seeking dividend eligibility must hold shares before the ex-dividend date prior to October 23, 2026. Watch for Q2 FY27 earnings disclosures to assess overall cash generation and booking trends.
LTM Declares ₹25/Share Interim Dividend; Q2 Revenue Rises to ₹11,807.6 Cr
LTM Limited announced an interim dividend of ₹25 per equity share of face value ₹1 for FY27, setting the record date as October 23, 2026. Alongside the dividend, the company reported consolidated Q2 revenue from operations of ₹11,807.6 crore (₹118,076 million), up 13.6% YoY from ₹10,394.3 crore (₹103,943 million) in Q2 FY26. Consolidated profit before tax stood at ₹1,859.7 crore (₹18,597 million) for the quarter. The dividend payout is scheduled to be completed within 30 days of declaration.
Confidence: HIGH
What changedThe Board declared an interim dividend of ₹25 per share and approved unaudited financial results for Q2 ended September 30, 2026.
Why it mattersProvides immediate cash return to shareholders backed by continued top-line growth (Q2 revenue up ~13.6% YoY).
Interim dividend per share: INR 25/-Record date: October 23, 2026Q2 Consolidated Revenue: 118,076 millionQ2 Consolidated PBT: 18,597 million
📅 Short termThe stock will trade ex-dividend ahead of October 23, 2026; price action will also digest the Q2 earnings release and margin performance.
📈 Long termDemonstrates consistent capital return policy and business stability as revenue expanded to ₹11,807.6 crore for the quarter.
Key Highlights
Declared interim dividend of INR 25/- per equity share of Re. 1 each
Record date fixed as Friday, October 23, 2026
Q2 revenue from operations reported at INR 118,076 million vs INR 103,943 million in Q2 prior year
Profit before tax stood at INR 18,597 million for the quarter ended September 30, 2026
Appointed Mr. Anupam Kumar as Additional Non-Executive Non-Independent Director effective October 16, 2026
👀 What to Watch
Eligible shareholders must hold shares before the record date of October 23, 2026, to receive the ₹25 dividend. Investors should also monitor commentary from the Q2 earnings call regarding margin trajectory and demand outlook.
Oberoi Realty Q2 FY27 Consol Revenue at ₹1,670.95 Cr, Down 6% YoY
Oberoi Realty reported Q2 FY27 consolidated revenue from operations of ₹1,670.95 crore (₹1,67,095 lakh), down 6.1% YoY compared to ₹1,779.04 crore in Q2 FY26, but up 28.4% QoQ from ₹1,300.89 crore. For the half-year ended September 30, 2026, standalone profit before tax rose 32.0% YoY to ₹1,583.87 crore from ₹1,199.69 crore. Standalone net operating cash flow for H1 FY27 came in at ₹902.68 crore compared to ₹990.99 crore in the previous year.
Confidence: HIGH
What changedOberoi Realty's Board approved the unaudited financial results for the quarter and half-year ended September 30, 2026.
Why it mattersDemonstrates quarterly sequential revenue recovery and stable operational cash flows (₹902.68 cr in H1), maintaining high financial liquidity despite moderate YoY revenue contraction.
Consolidated Revenue (Q2 FY27): ₹1,670.95 crConsolidated Revenue (Q2 FY26): ₹1,779.04 crConsolidated Revenue (Q1 FY27): ₹1,300.89 crStandalone PBT (H1 FY27): ₹1,583.87 crStandalone Cash Flow from Operations (H1 FY27): ₹902.68 cr
📅 Short termSequential revenue expansion of 28.4% over Q1 provides operational support, though YoY revenue softness (-6.1%) may keep stock price action muted near term.
📈 Long termSolid operational cash generation and robust balance sheet structure provide stability as the company continues leasing out Commerz III and launches new MMR developments.
⚠ Risk flags
- Year-on-year contraction in quarterly consolidated revenue (-6.1%)
- Cyclicality in residential real estate recognition and MMR regional concentration
Key Highlights
Q2 FY27 consolidated revenue from operations at ₹1,670.95 cr vs ₹1,779.04 cr in Q2 FY26 (down 6.1% YoY)
Revenue expanded 28.4% sequentially compared to ₹1,300.89 cr in Q1 FY27
H1 FY27 standalone profit before tax stood at ₹1,583.87 cr, up 32.0% YoY from ₹1,199.69 cr
Standalone net cash inflow from operating activities stood at ₹902.68 cr in H1 FY27 vs ₹990.99 cr in H1 FY26
Standalone cash and cash equivalents at end of H1 FY27 reached ₹382.71 cr vs ₹125.51 cr in H1 FY26
👀 What to Watch
Track residential sales velocity, project delivery milestones for Thane (Jardin), and occupancy ramp-up across commercial assets like Commerz III in upcoming quarterly operational disclosures.
Modison Q2 FY27 PAT Jumps 100% YoY to Rs 23.29 Cr; Declares Rs 4 Interim Dividend
Modison Limited reported a strong Q2 FY27 consolidated revenue of Rs 279.03 Cr, marking a 92.2% YoY growth compared to Rs 145.16 Cr in Q2 FY26. Consolidated PAT for the quarter doubled (+99.7% YoY) to Rs 23.29 Cr against Rs 11.66 Cr in the year-ago period, though sequential PAT softened 31.2% from Rs 33.84 Cr in Q1 FY27. For H1 FY27, net profit stood at Rs 57.13 Cr compared to Rs 16.47 Cr in H1 FY26. The Board also declared an interim dividend of Rs 4 per share (400% on face value Rs 1) with a record date of October 23, 2026.
Confidence: HIGH
What changedModison reported its Q2 and H1 FY27 results and declared an interim dividend of Rs 4 per share.
Why it mattersDemonstrates sustained top-line scale (>Rs 270 Cr quarterly run rate) compared to FY26 levels, reflecting market share gains in switchgear electrical contacts.
Q2 Consolidated Revenue: Rs 27,902.59 LakhsQ2 Consolidated PAT: Rs 2,328.89 LakhsInterim Dividend per share: Rs 4/-Record Date: October 23, 2026H1 FY27 Revenue vs TTM Revenue: ~65.0%
📅 Short termMarket sentiment should react positively to the 100% YoY profit expansion and healthy interim dividend payout ahead of the October 23 record date.
📈 Long termScale indicates strong industry demand across HV/LV switchgear segments; sustainability hinges on managing raw material inflation and customer concentration.
⚠ Risk flags
- High raw material dependence with raw materials consumed surging to Rs 266.64 Cr
- Sequential contraction in PAT from Rs 33.84 Cr in Q1 FY27 to Rs 23.29 Cr in Q2 FY27
Key Highlights
Q2 FY27 consolidated revenue up 92.2% YoY to Rs 279.03 Cr (vs Rs 145.16 Cr)
Consolidated PAT rose 99.7% YoY to Rs 23.29 Cr from Rs 11.66 Cr in Q2 FY26
H1 FY27 revenue reached Rs 549.49 Cr, up 96.7% YoY from Rs 279.30 Cr
Declared an interim dividend of Rs 4/- per share (400%) with record date October 23, 2026
Basic EPS for Q2 FY27 stood at Rs 7.18 per share vs Rs 3.59 YoY
👀 What to Watch
Track the upcoming Q3 FY27 operational performance and margin trajectory to observe if the elevated raw material costs (Rs 266.64 Cr consumed) compress operating margins.
Modison Q2 FY27 PAT Jumps 100% YoY to Rs 23.29 Cr; Declares Rs 4 Interim Dividend
Modison Limited reported a strong Q2 FY27 consolidated revenue of Rs 279.03 Cr, marking a 92.2% YoY growth compared to Rs 145.16 Cr in Q2 FY26. Consolidated PAT for the quarter doubled (+99.7% YoY) to Rs 23.29 Cr against Rs 11.66 Cr in the year-ago period, though sequential PAT softened 31.2% from Rs 33.84 Cr in Q1 FY27. For H1 FY27, net profit stood at Rs 57.13 Cr compared to Rs 16.47 Cr in H1 FY26. The Board also declared an interim dividend of Rs 4 per share (400% on face value Rs 1) with a record date of October 23, 2026.
Confidence: HIGH
What changedModison reported its Q2 and H1 FY27 results and declared an interim dividend of Rs 4 per share.
Why it mattersDemonstrates sustained top-line scale (>Rs 270 Cr quarterly run rate) compared to FY26 levels, reflecting market share gains in switchgear electrical contacts.
Q2 Consolidated Revenue: Rs 27,902.59 LakhsQ2 Consolidated PAT: Rs 2,328.89 LakhsInterim Dividend per share: Rs 4/-Record Date: October 23, 2026H1 FY27 Revenue vs TTM Revenue: ~65.0%
📅 Short termMarket sentiment should react positively to the 100% YoY profit expansion and healthy interim dividend payout ahead of the October 23 record date.
📈 Long termScale indicates strong industry demand across HV/LV switchgear segments; sustainability hinges on managing raw material inflation and customer concentration.
⚠ Risk flags
- High raw material dependence with raw materials consumed surging to Rs 266.64 Cr
- Sequential contraction in PAT from Rs 33.84 Cr in Q1 FY27 to Rs 23.29 Cr in Q2 FY27
Key Highlights
Q2 FY27 consolidated revenue up 92.2% YoY to Rs 279.03 Cr (vs Rs 145.16 Cr)
Consolidated PAT rose 99.7% YoY to Rs 23.29 Cr from Rs 11.66 Cr in Q2 FY26
H1 FY27 revenue reached Rs 549.49 Cr, up 96.7% YoY from Rs 279.30 Cr
Declared an interim dividend of Rs 4/- per share (400%) with record date October 23, 2026
Basic EPS for Q2 FY27 stood at Rs 7.18 per share vs Rs 3.59 YoY
👀 What to Watch
Track the upcoming Q3 FY27 operational performance and margin trajectory to observe if the elevated raw material costs (Rs 266.64 Cr consumed) compress operating margins.
